GLP-1 medications have become game changers for people trying to lose weight ... Loss Center, agreed. “We've never had such a good obesity medicine,” Levy tells TODAY.com. She was not involved in the ...

Filipino doctors are calling for more public awareness to treat obesity as a chronic disease, not merely as a lifestyle ...

A phased rollout of Mounjaro is set to begin across the UK next week as GP surgeries issue an urgent warning to patients.

They were designed to treat diabetes, then prescribed for weight loss, and now—as researchers are finding—they might hold the ...

WEIGHT loss jabs, including Mounjaro and Wegovy, have been linked to more than 100 deaths in the UK, new figures have revealed. But none of the fatalities are proven to have been caused directly ...

Some blind vision loss cases have been linked to the use of weight-loss jabs, including Ozempic, so caution is recommended by ...

Novo Nordisk A/S shares are staging a comeback after a tumultuous year for the maker of Ozempic and Wegovy. The stock is up ...

Diagnosed prevalent cases are expected to increase to 14.63 million in 2031. Rising obesity cases in India present growth ...

On top of that, an analyst cut his price target on the Denmark-based pharmaceutical company. Novo Nordisk (NYSE: NVO) stock ...

A private equity firm has stepped in to finance a biological research lab at Harvard University, administrators said Monday, ...

U.S. drugmaker Eli Lilly said on Monday it will offer the higher-dose versions of its popular weight-loss drug Zepbound on ...

Big drugmakers are abusing the drug patent process to generate extra revenue at the cost of patients, according to a new ...